Evolent Health Company Profile (NYSE:EVH)

About Evolent Health (NYSE:EVH)

Evolent Health logoEvolent Health, Inc. is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population health management. The Company provides an end-to-end, technology-enabled services platform for providers. The Company's platform, powered by its technology, processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to payment models that reward value-based payment models. The Company's services include providing its customers, with a population management platform, integrated data and analytics capabilities, pharmacy benefit management (PBM) services and comprehensive health plan administration services. Its value-based operations are empowered and supported by Identifi. Identifi is the Company's technology platform that aggregates and analyzes data, manages care workflows and engages patients.

Industry, Sector and Symbol:
  • Sector:
  • Industry: Healthcare Information Services
  • Sub-Industry: N/A
  • Symbol: NYSE:EVH
  • CUSIP: N/A
  • Web: www.evolenthealth.com
Capitalization:
  • Market Cap: $1.36 billion
  • Outstanding Shares: 57,724,000
Average Prices:
  • 50 Day Moving Avg: $23.12
  • 200 Day Moving Avg: $19.84
  • 52 Week Range: $14.50 - $26.84
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 391.67
  • P/E Growth: -1.94
Sales & Book Value:
  • Annual Revenue: $310.98 million
  • Price / Sales: 4.36
  • Book Value: $13.16 per share
  • Price / Book: 1.79
Profitability:
  • EBIDTA: ($50,960,000.00)
  • Net Margins: -69.04%
  • Return on Equity: -5.54%
  • Return on Assets: -5.02%
Debt:
  • Current Ratio: 2.93%
  • Quick Ratio: 2.93%
Misc:
  • Average Volume: 979,653 shs.
  • Beta: 1.28
  • Short Ratio: 13.58
 

Frequently Asked Questions for Evolent Health (NYSE:EVH)

What is Evolent Health's stock symbol?

Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."

How were Evolent Health's earnings last quarter?

Evolent Health Inc (NYSE:EVH) announced its earnings results on Tuesday, May, 9th. The company reported ($0.26) EPS for the quarter, missing the consensus estimate of ($0.15) by $0.11. The business had revenue of $106.80 million for the quarter, compared to the consensus estimate of $104.38 million. Evolent Health had a negative return on equity of 5.54% and a negative net margin of 69.04%. Evolent Health's revenue for the quarter was up 116.2% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.16) EPS. View Evolent Health's Earnings History.

Where is Evolent Health's stock going? Where will Evolent Health's stock price be in 2017?

11 brokers have issued 1 year price targets for Evolent Health's stock. Their forecasts range from $24.00 to $31.00. On average, they anticipate Evolent Health's stock price to reach $27.88 in the next year. View Analyst Ratings for Evolent Health.

What are analysts saying about Evolent Health stock?

Here are some recent quotes from research analysts about Evolent Health stock:

  • 1. According to Zacks Investment Research, "Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. " (5/4/2017)
  • 2. Cantor Fitzgerald analysts commented, "4Q16 results were solid. Adjusted 4Q16 revenue of $90 million (+92.6% y/y) was above consensus expectations of $85.3 million. Revenue included contributions from Valence and Aldera. Revenue growth was driven by contributions from Valence and Aldera and by an increase in the number of lives on the company’s platform. The number of lives grew 181.5% y/y, reaching about 2.0 million lives in 4Q16. EVH also added another 600,000 lives to the platform in January 2017. Adjusted transformation revenue of $12.1 million increased 12% y/y. Transformation revenue can fluctuate quarter-to-quarter due to the timing of customer contracts and the scope of delivery. Adjusted platform and operation revenue of $77.9 million (+116.8%) benefited from an increased number of lives on the platform. Average PMPM was $12.87 in 4Q16 vs. $16.70." (3/1/2017)

Who are some of Evolent Health's key competitors?

Who are Evolent Health's key executives?

Evolent Health's management team includes the folowing people:

  • Seth Blackley, President
  • Frank John Williams, Chief Executive Officer, Director
  • Nicholas P. McGrane, Chief Financial Officer
  • Thomas Peterson III, Chief Operating Officer
  • Charles W. Pomeroy Jr., Chief Technology Officer
  • Lydia Stone, Principal Accounting Officer, Corporate Controller
  • Jonathan D. Weinberg, General Counsel
  • Dave Thornton, Chief Talent Officer
  • Steven J. Wigginton, Chief Development Officer
  • Michael D'Amato, Director

When did Evolent Health IPO?

(EVH) raised $150 million in an initial public offering (IPO) on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Who owns Evolent Health stock?

Evolent Health's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include JPMorgan Chase & Co. (9.62%), FMR LLC (8.61%), Pennant Capital Management LLC (5.41%), Vanguard Group Inc. (4.81%), TPG Group Holdings SBS Advisors Inc. (2.50%) and TimesSquare Capital Management LLC (2.49%). Company insiders that own Evolent Health stock include Board Co Advisory, Chad Pomeroy, Cheryl Scott, Frank J Williams, Gary Piefer, Jonathan Weinberg, Michael D'amato, Nicholas Mcgrane, Seth Blackley, Steve Wigginton, Thomas Peterson III, Tpg Growth Ii Advisors, Inc and Upmc. View Institutional Ownership Trends for Evolent Health.

Who sold Evolent Health stock? Who is selling Evolent Health stock?

Evolent Health's stock was sold by a variety of institutional investors in the last quarter, including Granahan Investment Management Inc. MA, TPG Group Holdings SBS Advisors Inc., Peregrine Capital Management LLC, Credit Suisse AG, Gilder Gagnon Howe & Co. LLC, TimesSquare Capital Management LLC, Morgan Stanley and Bank of New York Mellon Corp. Company insiders that have sold Evolent Health stock in the last year include Board Co Advisory, Chad Pomeroy, Cheryl Scott, Frank J Williams, Jonathan Weinberg, Nicholas Mcgrane, Seth Blackley, Steve Wigginton, Thomas Peterson III, Tpg Growth Ii Advisors, Inc and Upmc. View Insider Buying and Selling for Evolent Health.

Who bought Evolent Health stock? Who is buying Evolent Health stock?

Evolent Health's stock was bought by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., FMR LLC, MARSHALL WACE ASIA Ltd, Marshall Wace North America L.P., Mackenzie Financial Corp, UBS Asset Management Americas Inc., Vanguard Group Inc. and Edmond DE Rothschild Holding S.A.. Company insiders that have bought Evolent Health stock in the last two years include Gary Piefer and Michael D'amato. View Insider Buying and Selling for Evolent Health.

How do I buy Evolent Health stock?

Shares of Evolent Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Evolent Health's stock price today?

One share of Evolent Health stock can currently be purchased for approximately $23.50.


MarketBeat Community Rating for Evolent Health (NYSE EVH)
Community Ranking:  3.9 out of 5 (  )
Outperform Votes:  165 (Vote Outperform)
Underperform Votes:  48 (Vote Underperform)
Total Votes:  213
MarketBeat's community ratings are surveys of what our community members think about Evolent Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Evolent Health (NYSE:EVH) (?)
Ratings Breakdown: 10 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 3.09)
Consensus Price Target: $27.88 (18.62% upside)

Analysts' Ratings History for Evolent Health (NYSE:EVH)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
4/13/2017Jefferies Group LLCReiterated RatingBuy$28.00LowView Rating Details
3/14/2017CIBCInitiated CoverageOutperform -> OutperformLowView Rating Details
3/13/2017Oppenheimer Holdings Inc.Initiated CoverageOutperform$28.00LowView Rating Details
3/8/2017Goldman Sachs Group IncUpgradeBuy -> Conviction-Buy$30.00MediumView Rating Details
3/1/2017Cantor FitzgeraldReiterated RatingBuy$26.00N/AView Rating Details
2/28/2017Leerink SwannSet Price TargetBuy$24.00N/AView Rating Details
2/3/2017Canaccord GenuityReiterated RatingBuy$31.00N/AView Rating Details
1/13/2017Wells Fargo & CoUpgradeMarket Perform -> OutperformN/AView Rating Details
10/28/2016JPMorgan Chase & Co.Initiated CoverageOverweight$30.00N/AView Rating Details
9/30/2016William BlairReiterated RatingOutperformN/AView Rating Details
8/5/2016FBR & CoBoost Price TargetOutperform$24.00 -> $26.00N/AView Rating Details
6/30/2015SunTrust Banks, Inc.Initiated CoverageBuy$24.00N/AView Rating Details
(Data available from 5/30/2015 forward)

Earnings

Earnings History for Evolent Health (NYSE:EVH)
Earnings by Quarter for Evolent Health (NYSE:EVH)
Earnings History by Quarter for Evolent Health (NYSE EVH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2017Q1 2017($0.15)($0.26)$104.38 million$106.80 millionViewListenView Earnings Details
2/28/2017Q416($0.20)($0.35)$84.98 million$88.00 millionViewListenView Earnings Details
11/9/2016Q316($0.13)($0.26)$58.35 million$60.20 millionViewListenView Earnings Details
8/4/2016Q216($0.16)($0.12)$51.96 million$56.50 millionViewN/AView Earnings Details
5/12/2016Q116($0.19)($0.16)$47.40 million$49.50 millionViewListenView Earnings Details
2/25/2016Q415($0.21)($0.05)$43.73 million$46.70 millionViewListenView Earnings Details
11/5/2015Q315($0.21)($0.16)$42.51 million$43.30 millionViewN/AView Earnings Details
8/6/2015Q215($0.37)($1.00)$157.50 million$36.50 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Evolent Health (NYSE:EVH)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20171($0.11)($0.11)($0.11)
Q3 20171($0.08)($0.08)($0.08)
Q4 20171($0.03)($0.03)($0.03)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Evolent Health (NYSE:EVH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Evolent Health (NYSE:EVH)
Insider Ownership Percentage: 8.85%
Institutional Ownership Percentage: 52.14%
Insider Trades by Quarter for Evolent Health (NYSE:EVH)
Institutional Ownership by Quarter for Evolent Health (NYSE:EVH)
Insider Trades by Quarter for Evolent Health (NYSE:EVH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/19/2017Cheryl ScottDirectorSell5,477$23.51$128,764.27View SEC Filing  
5/19/2017Frank J. WilliamsCEOSell114,865$24.30$2,791,219.50View SEC Filing  
5/19/2017Jonathan WeinbergGeneral CounselSell17,230$24.30$418,689.00View SEC Filing  
5/19/2017Nicholas McgraneCFOSell47,508$24.30$1,154,444.40View SEC Filing  
5/19/2017Thomas Peterson IIICOOSell57,433$24.30$1,395,621.90View SEC Filing  
5/19/2017Tpg Growth Ii Advisors, Inc.InsiderSell3,081,760$24.30$74,886,768.00View SEC Filing  
5/19/2017UpmcMajor ShareholderSell2,333,333$24.30$56,699,991.90View SEC Filing  
5/15/2017Seth BlackleyPresidentSell15,000$25.00$375,000.00View SEC Filing  
5/15/2017Thomas Peterson IIICOOSell83,108$24.99$2,076,868.92View SEC Filing  
5/10/2017Nicholas McgraneInsiderSell1,667$24.28$40,474.76View SEC Filing  
5/10/2017Thomas Peterson IIICOOSell18,604$25.00$465,100.00View SEC Filing  
5/4/2017Frank J WilliamsCEOSell16,300$23.55$383,865.00View SEC Filing  
5/3/2017Jonathan WeinbergGeneral CounselSell15,000$23.85$357,750.00View SEC Filing  
5/1/2017Steve WiggintonCEOSell6,000$23.10$138,600.00View SEC Filing  
5/1/2017UpmcMajor ShareholderSell403,644$19.53$7,883,167.32View SEC Filing  
4/19/2017Nicholas McgraneCFOSell1,667$22.52$37,540.84View SEC Filing  
4/17/2017Seth BlackleyPresidentSell15,000$21.48$322,200.00View SEC Filing  
4/6/2017Frank J WilliamsCEOSell16,300$22.03$359,089.00View SEC Filing  
4/3/2017Steve WiggintonCEOSell6,000$23.15$138,900.00View SEC Filing  
3/31/2017UpmcMajor ShareholderSell2,690,961$19.53$52,554,468.33View SEC Filing  
3/30/2017Seth BlackleyPresidentSell15,000$21.19$317,850.00View SEC Filing  
3/28/2017Board Co AdvisoryMajor ShareholderSell2,118,078$19.53$41,366,063.34View SEC Filing  
3/24/2017Nicholas McgraneCFOSell7,034$22.50$158,265.00View SEC Filing  
1/30/2017Seth BlackleyPresidentSell15,000$17.58$263,700.00View SEC Filing  
1/17/2017Seth BlackleyPresidentSell30,000$17.98$539,400.00View SEC Filing  
11/14/2016Michael D'amatoDirectorBuy10,000$17.18$171,800.00View SEC Filing  
9/22/2016Board Co AdvisoryMajor ShareholderSell317,712$22.50$7,148,520.00View SEC Filing  
9/14/2016Board Co AdvisoryMajor ShareholderSell1,936,529$22.50$43,571,902.50View SEC Filing  
9/14/2016Chad PomeroyInsiderSell55,180$21.54$1,188,577.20View SEC Filing  
9/14/2016Frank J WilliamsCEOSell251,481$21.54$5,416,900.74View SEC Filing  
9/14/2016Jonathan WeinbergGeneral CounselSell10,339$21.54$222,702.06View SEC Filing  
9/14/2016Nicholas McgraneCFOSell21,205$21.54$456,755.70View SEC Filing  
9/14/2016Seth BlackleyPresidentSell167,672$21.54$3,611,654.88View SEC Filing  
9/14/2016Thomas Peterson IIICOOSell72,827$21.54$1,568,693.58View SEC Filing  
6/10/2015Gary PieferInsiderBuy2,000$17.00$34,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Evolent Health (NYSE:EVH)
Latest Headlines for Evolent Health (NYSE:EVH)
Source:
DateHeadline
americanbankingnews.com logoEvolent Health Inc (EVH) Stock Rating Upgraded by TheStreet
www.americanbankingnews.com - May 25 at 2:42 PM
americanbankingnews.com logoInsider Selling: Evolent Health Inc (EVH) Director Sells 5,477 Shares of Stock
www.americanbankingnews.com - May 23 at 8:19 PM
americanbankingnews.com logoEvolent Health Inc (EVH) General Counsel Jonathan Weinberg Sells 17,230 Shares
www.americanbankingnews.com - May 23 at 7:47 PM
americanbankingnews.com logoEvolent Health Inc (EVH) COO Sells $1,395,621.90 in Stock
www.americanbankingnews.com - May 23 at 7:27 PM
americanbankingnews.com logoEvolent Health Inc (EVH) Insider Sells $74,886,768.00 in Stock
www.americanbankingnews.com - May 23 at 7:26 PM
americanbankingnews.com logoInsider Selling: Evolent Health Inc (EVH) CEO Sells $2,791,219.50 in Stock
www.americanbankingnews.com - May 23 at 7:26 PM
americanbankingnews.com logoEvolent Health Inc (EVH) CFO Sells $1,154,444.40 in Stock
www.americanbankingnews.com - May 23 at 7:26 PM
americanbankingnews.com logoInsider Selling: Evolent Health Inc (EVH) Major Shareholder Sells 2,333,333 Shares of Stock
www.americanbankingnews.com - May 22 at 4:29 PM
americanbankingnews.com logoEvolent Health Inc (EVH) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 22 at 8:22 AM
finance.yahoo.com logoETFs with exposure to Evolent Health, Inc. : May 18, 2017
finance.yahoo.com - May 19 at 5:31 AM
americanbankingnews.com logoEvolent Health Inc (EVH) COO Thomas Peterson III Sells 83,108 Shares
www.americanbankingnews.com - May 17 at 10:29 PM
americanbankingnews.com logoInsider Selling: Evolent Health Inc (EVH) President Sells 15,000 Shares of Stock
www.americanbankingnews.com - May 17 at 7:47 PM
nasdaq.com logoEvolent Health (EVH) Prices 7M Follow-On Share Offering - Nasdaq
www.nasdaq.com - May 17 at 5:03 PM
streetinsider.com logoEvolent Health (EVH) Prices 7M Share Upsized Secondary Offering at $24.65/Sh
www.streetinsider.com - May 16 at 11:50 AM
finance.yahoo.com logoEvolent Health, Inc. Announces Pricing of Upsized Secondary Public Offering of Class A Common Stock
finance.yahoo.com - May 16 at 11:50 AM
finance.yahoo.com logoEvolent Health, Inc. :EVH-US: Earnings Analysis: Q1, 2017 By the Numbers : May 16, 2017
finance.yahoo.com - May 16 at 11:50 AM
americanbankingnews.com logoQ2 2017 Earnings Forecast for Evolent Health Inc Issued By Leerink Swann (EVH)
www.americanbankingnews.com - May 15 at 7:58 AM
americanbankingnews.com logoEvolent Health Inc (EVH) COO Sells $465,100.00 in Stock
www.americanbankingnews.com - May 12 at 10:50 PM
americanbankingnews.com logoEvolent Health Inc (EVH) Insider Nicholas Mcgrane Sells 1,667 Shares
www.americanbankingnews.com - May 12 at 8:26 PM
seekingalpha.com logoEvolent Health's (EVH) CEO Frank Williams on Q1 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 10 at 8:10 AM
prnewswire.com logoEvolent Health Announces First Quarter 2017 Results - PR Newswire (press release)
www.prnewswire.com - May 10 at 8:10 AM
finance.yahoo.com logoEvolent Health reports 1Q loss
finance.yahoo.com - May 10 at 8:10 AM
finance.yahoo.com logoEdited Transcript of EVH earnings conference call or presentation 9-May-17 9:00pm GMT
finance.yahoo.com - May 10 at 8:10 AM
americanbankingnews.com logoEvolent Health Inc (EVH) Releases Earnings Results, Beats Estimates By $0.02 EPS
www.americanbankingnews.com - May 9 at 11:02 PM
finance.yahoo.com logoEvolent Health and Community Care Cooperative to Transform Value-Based Care in Massachusetts
finance.yahoo.com - May 9 at 4:58 PM
finance.yahoo.com logoEvolent Health Partners with Houston Methodist to Drive Value-Based Care in Texas
finance.yahoo.com - May 9 at 4:58 PM
finance.yahoo.com logoEvolent Health Announces First Quarter 2017 Results
finance.yahoo.com - May 9 at 4:58 PM
reuters.com logoTPG Growth to acquire medical staffing firm Medical Solutions
www.reuters.com - May 9 at 9:13 AM
americanbankingnews.com logoInsider Selling: Evolent Health Inc (EVH) CEO Sells 16,300 Shares of Stock
www.americanbankingnews.com - May 8 at 7:36 PM
nasdaq.com logoTPG Growth to acquire medical staffing firm Medical Solutions - Nasdaq
www.nasdaq.com - May 8 at 4:57 PM
americanbankingnews.com logoEvolent Health Inc (EVH) General Counsel Sells $357,750.00 in Stock
www.americanbankingnews.com - May 5 at 8:36 PM
finance.yahoo.com logoEvolent Health to Host Investor and Analyst Day on May 11, 2017
finance.yahoo.com - May 5 at 5:18 PM
americanbankingnews.com logoEvolent Health Inc (EVH) Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - May 4 at 9:48 PM
americanbankingnews.com logoEvolent Health Inc (EVH) CEO Sells $138,600.00 in Stock
www.americanbankingnews.com - May 3 at 11:12 PM
americanbankingnews.com logoEvolent Health Inc (EVH) Upgraded at Zacks Investment Research
www.americanbankingnews.com - May 3 at 9:54 PM
americanbankingnews.com logoInsider Selling: Evolent Health Inc (EVH) Major Shareholder Sells 403,644 Shares of Stock
www.americanbankingnews.com - May 3 at 6:56 PM
nasdaq.com logoCommit To Purchase Evolent Health At $17.50, Earn 8.3% Annualized Using Options
www.nasdaq.com - May 3 at 4:55 PM
americanbankingnews.com logoEvolent Health (EVH) Earning Very Favorable Media Coverage, AlphaOne Reports
www.americanbankingnews.com - May 2 at 4:16 PM
americanbankingnews.com logoEvolent Health (EVH) Getting Positive News Coverage, Study Finds
www.americanbankingnews.com - April 28 at 6:20 PM
americanbankingnews.com logo-$0.15 Earnings Per Share Expected for Evolent Health Inc (EVH) This Quarter
www.americanbankingnews.com - April 28 at 11:09 AM
americanbankingnews.com logoEvolent Health Inc (EVH) CFO Nicholas Mcgrane Sells 1,667 Shares
www.americanbankingnews.com - April 21 at 9:30 PM
finance.yahoo.com logoEvolent Health, Inc. to Release First Quarter 2017 Operating Results and Host Conference Call on Tuesday, …
finance.yahoo.com - April 21 at 5:07 PM
finance.yahoo.com logoEvolent Health, Inc. to Release First Quarter 2017 Operating Results and Host Conference Call on Tuesday, May 9, 2017
finance.yahoo.com - April 21 at 5:07 PM
americanbankingnews.com logoEvolent Health (EVH) Receives Media Impact Score of 0.20
www.americanbankingnews.com - April 18 at 4:08 PM
americanbankingnews.com logoEvolent Health (EVH) Earning Very Favorable Media Coverage, Analysis Finds
www.americanbankingnews.com - April 15 at 8:26 AM
americanbankingnews.com logoEvolent Health Inc (EVH) Given a $28.00 Price Target by Jefferies Group LLC Analysts
www.americanbankingnews.com - April 13 at 7:26 PM
americanbankingnews.com logoEvolent Health Inc (EVH) CEO Frank J. Williams Sells 16,300 Shares
www.americanbankingnews.com - April 10 at 7:51 PM
bizjournals.com logoResearch Reports Coverage on Healthcare Information Services Stocks -- Evolent, HealthEquity, Premier, and Medidata Solutions
www.bizjournals.com - April 7 at 9:43 AM
americanbankingnews.com logoEvolent Health Inc (EVH) Expected to Post Earnings of -$0.15 Per Share
www.americanbankingnews.com - April 6 at 8:22 PM
americanbankingnews.com logoInsider Selling: Evolent Health Inc (EVH) CEO Sells 6,000 Shares of Stock
www.americanbankingnews.com - April 5 at 8:52 PM

Social

Chart

Evolent Health (EVH) Chart for Tuesday, May, 30, 2017

This page was last updated on 5/30/2017 by MarketBeat.com Staff